• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Shriners Hospitals for Children Launches New Genomics Institute to Advance Precision Medicine

by Jasmine Pennic 10/31/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Shriners Hospitals for Children Expands Implementation of Tonic Health’s Mobile Patient Survey Platform

– Shriners Hospitals for Children establishes new genomics institute to advance precision medicine in partnership with Genome Medical to return actionable genetic findings for pediatric patients.

– Genomics Institute at Shriners Hospitals will offer genetic sequencing to patients at its 22 hospitals and outpatient locations in North America and from its international network of outreach clinics.

Shriners Hospitals for Children is teaming up with Genome Medical to ensure that pediatric patients and families receiving next-generation DNA sequencing through the new Genomics Institute at Shriners Hospitals will have access to the highest standard of genetic services through Genome Medical’s nationwide network of clinical genetic specialists. Together, Shriners Hospitals for Children and Genome Medical will be taking pediatric genetic research to a personalized, patient-centric level that will lead to more individualized treatment options and improved outcomes.

Genome Medical is a national telegenomics technology and services company bringing genomic medicine to everyday care. Through our nationwide network of genetic specialists and efficient Genome Care Delivery technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being.

Offering Genetic Sequencing to Patients across 22 Hospitals & Outpatient Facilities

The Shriners health care system will offer genetic sequencing to patients at its 22 hospitals and outpatient locations in North America and its international network of outreach clinics. For some patients, the sequencing will reveal genetic variations in the most medically actionable genes. These patients and their caregivers will be connected to Genome Medical to receive support and clinical guidance from its team of genetic counselors and medical geneticists, who specialize in pediatric conditions. This may include virtual genetic counseling, arranging confirmatory genetic testing for the patient, referrals to appropriate medical specialists for follow-on care, and coordinating genetic testing of family members when recommended.

Bringing A Genetics-Based Approach to Medical Care

This genetics-based approach to medical care — precision medicine — is more than a hope or a dream. It is becoming a reality, and one day will even be the standard. With the establishment of its Genomics Institute in Tampa, Florida, Shriners Hospitals for Children has taken a major step toward this goal of understanding the specific — and individual — genetic causes of various conditions and disabilities, such as cerebral palsy, cleft lip, and palate, clubfoot, scoliosis, and osteogenesis imperfecta.

Genome Medical is dedicated to accelerating the integration of genomic-based medicine into health care for patients all across the United States. For both individuals and organizations like Shriners Hospitals for Children, Genome Medical’s clinical team navigates the rapidly expanding field of genetics and utilizes test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

“Through sophisticated, next generation sequencing of DNA samples from our patient population, Shriners Hospitals hopes to gain the understanding needed to create more targeted, efficient and personalized treatments and therapies,” said Marc Lalande, Ph.D., vice president of research programs for Shriners Hospitals for Children. “We are proud to be at the forefront of this next major step toward bringing new hope and healing to children and families the world over.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Caregivers, dna, genomic medicine, genomics, patient population, Precision Medicine, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |